A recent randomized controlled trial-based meta-analysis proved that L-carnitine supplementation effectively reduced the serum levels of aspartate transaminase (AST), alanine transaminase (ALT) and TG and the homeostasis model assessment of insulin resistance (HOMA-IR) in patients with NAFLD [12]. This evidence concerns the gene GPT and Insulin resistance.